Kurt Zimmermann
Bristol-Myers Squibb (Germany)(DE)Discovery Centre(CA)
Publications by Year
Research Areas
Radiopharmaceutical Chemistry and Applications, Probiotics and Fermented Foods, Monoclonal and Polyclonal Antibodies Research, Growth Hormone and Insulin-like Growth Factors, Gut microbiota and health
Most-Cited Works
- → Site‐Specific and Stoichiometric Modification of Antibodies by Bacterial Transglutaminase(2010)326 cited
- → Tumor Development by Transgenic Expression of a Constitutively Active Insulin-Like Growth Factor I Receptor(2005)203 cited
- → Immunomodulatory consequences of oral administration of Lactobacillus rhamnosus strain GG in healthy volunteers(2003)141 cited
- → Discovery of a 1H-Benzoimidazol-2-yl)-1H-pyridin-2-one (BMS-536924) Inhibitor of Insulin-like Growth Factor I Receptor Kinase with in Vivo Antitumor Activity(2005)134 cited
- → Comparative genomic analysis for the presence of potential enterococcal virulence factors in the probiotic Enterococcus faecalis strain Symbioflor 1(2007)115 cited
- → Probiotic Potential and Safety Evaluation of Enterococcus faecalis OB14 and OB15, Isolated From Traditional Tunisian Testouri Cheese and Rigouta, Using Physiological and Genomic Analysis